Single agent versus combination chemotherapy for metastatic breast cancer
- 15 April 2009
- journal article
- research article
- Published by Wiley in Emergencias
- Vol. 2021 (5), CD003372
- https://doi.org/10.1002/14651858.cd003372.pub3
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- Achievements in Systemic Therapies in the Pregenomic Era in Metastatic Breast CancerThe Oncologist, 2007
- Evidence for the use of chemotherapy in breast cancerInternational Journal of Clinical Oncology, 2002
- VP-16 + adriamycin vs. Adriamycin alone in advanced adenocarcinoma of the breast, phase II, a randomized trial: A southwest oncology group studyMedical and Pediatric Oncology, 1988
- Weekly Adriamycin versus VAC in advanced breast cancer. A randomized trialEuropean Journal of Cancer and Clinical Oncology, 1986
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Adriamycin alone or combined with vincristine in the treatment of advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1983
- Single-drug vs combination cytotoxic chemotherapy in advanced breast cancer: A randomized studyEuropean Journal of Cancer (1965), 1980
- Improved remission rates and remission duration in young women with metastatic breast cancer following combined oophorectomy and chemotherapy. A study by cancer and leukemia group BCancer, 1979
- Combination chemotherapy and adriamycin in patients with advanced breast cancer.A Southwest Oncology Group studyCancer, 1976